Filing Details
- Accession Number:
- 0001209191-13-027423
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-17 20:07:50
- Reporting Period:
- 2013-05-15
- Filing Date:
- 2013-05-17
- Accepted Time:
- 2013-05-17 20:07:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1333458 | Joseph Robert Bujarski | 10165 Mckellar Court San Diego CA 92121 | Svp, Bus Dev & Gen Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-05-15 | 8,283 | $8.50 | 58,443 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-05-15 | 8,283 | $23.35 | 50,160 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-05-17 | 19,196 | $8.50 | 69,356 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-05-17 | 19,196 | $23.02 | 50,160 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option | Disposition | 2013-05-15 | 8,283 | $0.00 | 8,283 | $8.50 |
Common Stock | Non-Qualified Stock Option | Disposition | 2013-05-17 | 19,196 | $0.00 | 19,196 | $8.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
48,004 | 2013-04-10 | 2019-04-10 | No | 4 | M | Direct |
28,808 | 2013-04-10 | 2019-04-10 | No | 4 | M | Direct |
Footnotes
- The weighted average purchase price for these transactions was $23.3524 per share, with a range of $23.32 to $23.40 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
- The weighted average purchase price for these transactions was $23.0229 per share, with a range of $23.01 to $23.10 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.